Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRPOF Ceapro	$0.17	$0.17	$0.11 ▼ $0.40	$13.31M	1.47	15,466 shs	N/A
EYEG AB Corporate Bond ETF	$35.41 +1.9%	$1.90	$33.92 ▼ $37.24	$25.89M	0.16	1,375 shs	2,893 shs
GHSI Guardion Health Sciences	$3.22 -2.1%	$3.24	$3.04 ▼ $18.00	$4.35M	0.73	105,261 shs	4,700 shs
INNT Innovate Biopharmaceuticals		$0.97	$0.37 ▼ $1.67	$8K	-0.39	525,982 shs	1,648 shs
SXTC China SXT Pharmaceuticals	$1.71 -3.4%	$1.74	$0.95 ▼ $11.92	$205.37M	1.18	1.19 million shs	38,029 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRPOF Ceapro	0.00%	0.00%	0.00%	0.00%	0.00%
EYEG AB Corporate Bond ETF	+0.21%	-0.21%	+1.09%	+2.98%	-0.51%
GHSI Guardion Health Sciences	0.00%	0.00%	0.00%	0.00%	-67.51%
INNT Innovate Biopharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
SXTC China SXT Pharmaceuticals	-3.39%	-6.30%	-18.96%	-31.33%	-80.02%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRPOF Ceapro	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EYEG AB Corporate Bond ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GHSI Guardion Health Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INNT Innovate Biopharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	0.1601 of 5 stars	0.0	3.0	0.0	0.0	0.0	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRPOF Ceapro	N/A	N/A	N/A
EYEG AB Corporate Bond ETF	N/A	N/A	N/A
GHSI Guardion Health Sciences	N/A	N/A	N/A
INNT Innovate Biopharmaceuticals	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRPOF Ceapro	$7.14M	1.86	$0.06 per share	2.74	$0.32 per share	0.53
EYEG AB Corporate Bond ETF	$10K	2,656.05	N/A	N/A	$1.26 per share	28.11
GHSI Guardion Health Sciences	$12.25M	0.35	$0.14 per share	23.15	$6.39 per share	0.50
INNT Innovate Biopharmaceuticals	N/A	N/A	N/A	N/A	($0.27) per share	N/A
SXTC China SXT Pharmaceuticals	$1.93M	102.80	N/A	N/A	$243.66 per share	0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRPOF Ceapro	-$3.49M	-$0.06	N/A	∞	N/A	-69.60%	-20.30%	-18.07%	N/A
EYEG AB Corporate Bond ETF	-$8.09M	-$1.68	N/A	N/A	N/A	N/A	-104.96%	-60.03%	N/A
GHSI Guardion Health Sciences	$160K	$4.87	0.66	∞	N/A	22.79%	-73.69%	-48.17%	N/A
INNT Innovate Biopharmaceuticals	-$27.05M	N/A	N/A	N/A	N/A	N/A	N/A	-234.42%	N/A
SXTC China SXT Pharmaceuticals	-$3.10M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRPOF Ceapro	N/A	N/A	N/A	N/A	N/A
EYEG AB Corporate Bond ETF	$2.10	5.93%	N/A	N/A	N/A
GHSI Guardion Health Sciences	$5.00	155.28%	N/A	102.67%	N/A
INNT Innovate Biopharmaceuticals	N/A	N/A	N/A	N/A	N/A
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Latest GHSI, EYEG, CRPOF, SXTC, and INNT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/30/2025	EYEG AB Corporate Bond ETF	Monthly	$0.1423	4.81%	7/1/2025	7/1/2025	7/7/2025
5/30/2025	EYEG AB Corporate Bond ETF	Monthly	$0.1507	5.19%	6/2/2025	6/2/2025	6/5/2025
4/30/2025	EYEG AB Corporate Bond ETF		$0.1501		5/1/2025	5/1/2025	5/6/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRPOF Ceapro	N/A	11.00	7.72
EYEG AB Corporate Bond ETF	0.01	3.07	3.07
GHSI Guardion Health Sciences	N/A	16.68	16.59
INNT Innovate Biopharmaceuticals	N/A	0.35	0.35
SXTC China SXT Pharmaceuticals	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRPOF Ceapro	N/A
EYEG AB Corporate Bond ETF	64.16%
GHSI Guardion Health Sciences	20.21%
INNT Innovate Biopharmaceuticals	5.88%
SXTC China SXT Pharmaceuticals	5.02%

Insider Ownership

Company	Insider Ownership
CRPOF Ceapro	N/A
EYEG AB Corporate Bond ETF	58.20%
GHSI Guardion Health Sciences	1.32%
INNT Innovate Biopharmaceuticals	7.90%
SXTC China SXT Pharmaceuticals	3.95%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRPOF Ceapro	N/A	78.29 million	N/A	Not Optionable
EYEG AB Corporate Bond ETF	14	750,000	5.28 million	Not Optionable
GHSI Guardion Health Sciences	10	1.35 million	1.33 million	Not Optionable
INNT Innovate Biopharmaceuticals	8	41.33 million	N/A	Not Optionable
SXTC China SXT Pharmaceuticals	90	116.03 million	111.45 million	Not Optionable

GHSI, EYEG, CRPOF, SXTC, and INNT Headlines

Recent News About These Companies

China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Price Down 10.1% - Here's Why

July 8 at 2:41 AM | marketbeat.com

China SXT Pharmaceuticals, Inc. (SXTC) - Yahoo Finance

July 4, 2025 | sg.finance.yahoo.com

China SXT Pharmaceuticals Inc News (SXTC) - Investing.com

June 25, 2025 | investing.com

China SXT Pharmaceuticals Issues 90 Million Shares Following Warrant Exercise

June 16, 2025 | tipranks.com

China SXT Pharmaceuticals Inc Ordinary Shares

April 23, 2025 | morningstar.comM

China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges

March 28, 2025 | tipranks.com

China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange

March 19, 2025 | tipranks.com

China SXT Pharmaceuticals regains compliance with Nasdaq

March 17, 2025 | markets.businessinsider.com

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency

March 17, 2025 | finance.yahoo.com

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency

March 17, 2025 | globenewswire.com

China SXT Pharmaceuticals Inc trading resumes

February 25, 2025 | markets.businessinsider.com

China SXT Pharmaceuticals Inc trading halted, volatility trading pause

February 25, 2025 | markets.businessinsider.com

China SXT Pharmaceuticals Inc trading halted, news pending

February 24, 2025 | markets.businessinsider.com

China SXT Pharmaceuticals Announces New Securities Purchase Agreement

January 27, 2025 | msn.com

China SXT Pharmaceuticals Inc (SXTC) Stock’s 0.02% Increase This Year: What’s the Story?

January 7, 2025 | bovnews.comB

China SXT Pharmaceuticals Inc (SXTC) Stock Price Reaches $0.51: What Factors Are Influencing This Level?

January 1, 2025 | bovnews.comB

China SXT Pharmaceuticals Inc (SXTC) Stock: Greater Than Its Current Valuation?

December 26, 2024 | bovnews.comB

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

October 7, 2024 | globenewswire.com

china sxt pharmaceuticals - SXTC

October 3, 2024 | foxbusiness.com

China SXT Pharmaceuticals (NASDAQ:SXTC) Stock, Short Interest Report

October 1, 2024 | benzinga.com

Can China SXT Pharmaceuticals Inc (SXTC) Stock rise from its doldrums?

July 24, 2024 | bovnews.comB

New MarketBeat Followers Over Time

Media Sentiment Over Time

GHSI, EYEG, CRPOF, SXTC, and INNT Company Descriptions

Ceapro OTCMKTS:CRPOF

$0.17 0.00 (0.00%)

As of 06/6/2024

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

AB Corporate Bond ETF NASDAQ:EYEG

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Guardion Health Sciences NASDAQ:GHSI

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Innovate Biopharmaceuticals NASDAQ:INNT

Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase IIb clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase I clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease, as well as product for the treatment of alcoholic steatohepatitis (ASH). In addition, the company holds rights for INN-329, a formulation of secretin that is used to enhance visualization in magnetic resonance cholangiopancreatography procedures that is in Phase III clinical trial. The company has a research collaboration with Massachusetts General Hospital for the treatment of ASH. Innovate Biopharmaceuticals, Inc. is based in Raleigh, North Carolina.

China SXT Pharmaceuticals NASDAQ:SXTC

$1.71 -0.06 (-3.39%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$1.71 0.00 (-0.06%)

As of 07/10/2025 07:50 PM Eastern

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time